Los Angeles Capital Management LLC Biocryst Pharmaceuticals Inc Transaction History

Los Angeles Capital Management LLC

$24.7 Billion
Q3 2024

A detailed history of Los Angeles Capital Management LLC transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Los Angeles Capital Management LLC holds 86,533 shares of BCRX stock, worth $648,132. This represents 0.0% of its overall portfolio holdings.

Number of Shares

86,533

Previous 97,577 11.32%

Holding current value

$648,132

Previous $603,000 8.96%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	SELL	$6.41 - $8.69 $70,792 - $95,972	-11,044 Reduced 11.32%	86,533 $657,000
Q2 2024 Aug 05, 2024	BUY	$4.13 - $6.79 $32,887 - $54,068	7,963 Added 8.89%	97,577 $603,000
Q1 2024 Apr 05, 2024	BUY	$4.89 - $7.65 $177,428 - $277,572	36,284 Added 68.04%	89,614 $455,000
Q4 2023 Feb 06, 2024	BUY	$4.98 - $6.77 $100,605 - $136,767	20,202 Added 60.98%	53,330 $319,000
Q3 2023 Nov 06, 2023	BUY	$6.71 - $7.92 $3,395 - $4,007	506 Added 1.55%	33,128 $234,000
Q2 2023 Aug 03, 2023	BUY	$6.96 - $8.81 $227,049 - $287,399	32,622 New	32,622 $229,000
Q3 2022 Nov 02, 2022	BUY	$10.79 - $14.81 $154,135 - $211,560	14,285 New	14,285 $180,000
Q2 2021 Aug 05, 2021	SELL	$9.5 - $17.24 $294,025 - $533,578	-30,950 Closed	0 $0
Q1 2021 May 05, 2021	SELL	$7.37 - $13.61 $1.09 Million - $2.01 Million	-147,375 Reduced 82.64%	30,950 $314,000
Q4 2020 Feb 04, 2021	BUY	$3.37 - $8.61 $164,641 - $420,641	48,855 Added 37.73%	178,325 $1.33 Million
Q3 2020 Nov 02, 2020	BUY	$3.43 - $5.53 $159,546 - $257,227	46,515 Added 56.07%	129,470 $445,000
Q2 2020 Aug 05, 2020	SELL	$1.9 - $5.61 $68,827 - $203,222	-36,225 Reduced 30.4%	82,955 $394,000
Q1 2020 May 04, 2020	BUY	$1.6 - $4.11 $48,208 - $123,834	30,130 Added 33.83%	119,180 $238,000
Q4 2019 Feb 07, 2020	BUY	$1.59 - $3.45 $141,589 - $307,222	89,050 New	89,050 $307,000
Q4 2017 Feb 05, 2018	SELL	$4.16 - $5.33 $104,707 - $134,156	-25,170 Closed	0 $0
Q3 2017 Nov 06, 2017	BUY	$4.1 - $5.97 $103,196 - $150,264	25,170	25,170 $132,000

Others Institutions Holding BCRX

# of Institutions

279

Shares Held

172M

Call Options Held

625K

Put Options Held

739K

View Full List

About BIOCRYST PHARMACEUTICALS INC

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.39B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

More about BCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Los Angeles Capital Management LLC with notifications on news.

Account

Los Angeles Capital Management LLC Biocryst Pharmaceuticals Inc Transaction History